A recent study revealed, that the pharmaceutical industry is significantly more emission-intensive than the automotive industry1. In a cradle-to-grave perspective, the impact of supply chain on the carbon footprint of pharmaceutical companies operations by far exceeds the impacts related to waste production and treatment2, 3.

Therefore, it is of highest priority that pharmaceutical manufacturing becomes more efficient regarding the use of resources.

In this webinar, we:

  • Extensively describe the optimization of the manufacturing process of a pharmaceutical intermediate
  • Demonstrate that yield can be improved substantially via suitable reaction engineering
  • Show that the implemented optimizations come along with a net increase in quality of the obtained intermediate

  1. L. Belkhir, A. Elmeligi, Journal of Cleaner Production, 2019, 214, 185-194.
  2. C. Jimenez-Gonzalez, C. S. Ponder, Q. B. Broxterman, J. B. Manley, Org. Process Res. Dev. 2011, 15, 4, 912–917.
  3. Lonza Sustainability Report 2021, 2022, 35 ff.
You may also be interested in:
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content
Latest briefing from the Knowledge Center